Please wait a minute...
文章检索
预防医学  2023, Vol. 35 Issue (7): 557-562    DOI: 10.19485/j.cnki.issn2096-5087.2023.07.002
  论著 本期目录 | 过刊浏览 | 高级检索 |
2011—2022年宁波市胃癌发病和死亡趋势分析
王永, 包凯芳, 王思嘉, 陈洁平, 崔军, 应焱燕, 朱银潮, 李思萱, 徐典
宁波市疾病预防控制中心慢性非传染性疾病防制所,浙江 宁波 315010
Trends in incidence and mortality of gastric cancer in Ningbo City from 2011 to 2022
WANG Yong, BAO Kaifang, WANG Sijia, CHEN Jieping, CUI Jun, YING Yanyan, ZHU Yinchao, LI Sixuan, XU Dian
Department of Non-communicable Diseases Control and Prevention, Ningbo Center for Disease Control and Prevention, Ningbo, Zhejiang 315010, China
全文: PDF(819 KB)  
输出: BibTeX | EndNote (RIS)      
摘要 目的 了解2011—2022年浙江省宁波市胃癌发病和死亡趋势,为完善胃癌防制策略提供依据。方法 通过宁波市慢性病发病监测系统和死因监测系统收集2011—2022年宁波市胃癌发病和死亡资料,计算粗发病率和粗死亡率;采用2010年中国第六次人口普查数据计算中国人口标化率(中标率),采用Segi's 1960世界标准人口构成计算世界人口标化率(世标率);采用年度变化百分比(APC)和平均年度变化百分比(AAPC)分析胃癌发病和死亡趋势。结果 2011—2022年宁波市胃癌粗发病率为45.69/10万,无明显变化趋势(AAPC=-0.02%,P>0.05);中标发病率和世标发病率分别为28.61/10万和21.87/10万,均呈下降趋势(AAPC=-3.19%、-3.05%,均P<0.05)。粗死亡率、中标死亡率和世标死亡率分别为28.56/10万、17.07/10万和12.57/10万,均呈下降趋势(AAPC=-3.00%、-6.26%、-6.34%,均P<0.05)。城市和农村居民胃癌中标发病率、世标发病率、中标死亡率和世标死亡率均呈下降趋势(城市:AAPC=-2.72%、-2.53%、-5.91%、-5.96%,均P<0.05;农村:AAPC=-3.61%和-3.53%、-6.79%、-6.89%,均P<0.05);城市居民上述指标均高于农村居民。男性和女性胃癌中标发病率、世标发病率、中标死亡率和世标死亡率均呈下降趋势(男性:AAPC=-3.18%、-3.00%、-5.82%、-5.91%,均P<0.05;女性:AAPC=-2.98%、-2.90%、-7.12%、-7.12%,均P<0.05);男性上述指标均高于女性。宁波市居民胃癌粗发病率和粗死亡率均随年龄增长呈上升趋势(均P<0.05)。结论 2011—2022年宁波市居民胃癌发病率和死亡率均呈下降趋势,但发病和死亡水平仍较高,应重点关注男性和城市居民,加强40岁及以上人群胃癌筛查。
服务
把本文推荐给朋友
加入引用管理器
E-mail Alert
RSS
作者相关文章
王永
包凯芳
王思嘉
陈洁平
崔军
应焱燕
朱银潮
李思萱
徐典
关键词 胃癌发病率死亡率    
AbstractObjective To investigate the trends in incidence and mortality of gastric cancer in Ningbo City, Zhejiang Province from 2011 to 2022, so as to provide insights into improving gastric cancer control strategy. Methods The incidence and mortality of gastric cancer in Ningbo City from 2011 to 2022 were collected through Ningbo Municipal Chronic Disease and Cause of Death Monitoring System. The incidence and mortality of gastric cancer were calculated, and standardized by the data from the Sixth Chinese National Population Census in 2020 (Chinese-standardized rate) and the world standard population first introduced by Segi in 1960 (world-standardized rate). The trends in incidence and mortality of gastric cancer were evaluated using annual percent change (APC) and average annual percent change (AAPC). Results The crude incidence of gastric cancer was 45.69/105 in Ningbo City from 2011 to 2022, with no significant changing patterns seen during the study period (AAPC=-0.02%, P>0.05), and the Chinese- and world-standardized incidence of gastric cancer was 28.61/105 and 21.87/105, which both appeared a tendency towards a decline (AAPC=-3.19% and -3.05%, both P<0.05). The crude, Chinese-standardized and world-standardized mortality rates of gastric cancer were 28.56/105, 17.07/105 and 12.57/105, respectively, all showing a tendency towards a decline (AAPC=-3.00%, -6.26% and -6.34%, all P<0.05). The Chinese- and world-standardized incidence and mortality of gastric cancer all appeared a tendency towards a decline in urban (AAPC=-2.72%, -2.53%, -5.91% and -5.96%, all P<0.05) and rural areas (AAPC=-3.61%, -3.53%, -6.79% and -6.89%, all P<0.05), and the Chinese- and world-standardized incidence and mortality of gastric cancer were significantly higher among urban residents than among rural residents. The Chinese- and world-standardized incidence and mortality of gastric cancer all appeared a tendency towards a decline among men (AAPC=-3.18%, -3.00%, -5.82% and -5.91%, all P<0.05) and women (AAPC=-2.98%, -2.90%, -7.12% and -7.12%, all P<0.05), and the Chinese- and world-standardized incidence and mortality of gastric cancer was significantly higher among men than among women. In addition, the crude incidence and mortality of gastric cancer both appeared a tendency towards a rise with age among residents in Ningbo City (both P<0.05). Conclusions The incidence and mortality of gastric cancer both appeared a tendency towards a decline in Ningbo City from 2011 to 2022; however, the incidence and mortality remained high. Males and urban residents should be given a high priority for gastric cancer control, and gastric cancer screening should be strengthened among individuals at ages of 40 years and older.
Key wordsgastric cancer    incidence    mortality
收稿日期: 2023-05-09      修回日期: 2023-05-24      出版日期: 2023-07-10
中图分类号:  R246.5  
基金资助:宁波市医学重点学科(2022-B18); 宁波市公益类科技计划项目(2021S164)
作者简介: 王永,硕士,副主任医师,主要从事慢性病监测与防制工作
引用本文:   
王永, 包凯芳, 王思嘉, 陈洁平, 崔军, 应焱燕, 朱银潮, 李思萱, 徐典. 2011—2022年宁波市胃癌发病和死亡趋势分析[J]. 预防医学, 2023, 35(7): 557-562.
WANG Yong, BAO Kaifang, WANG Sijia, CHEN Jieping, CUI Jun, YING Yanyan, ZHU Yinchao, LI Sixuan, XU Dian. Trends in incidence and mortality of gastric cancer in Ningbo City from 2011 to 2022. Preventive Medicine, 2023, 35(7): 557-562.
链接本文:  
http://www.zjyfyxzz.com/CN/10.19485/j.cnki.issn2096-5087.2023.07.002      或      http://www.zjyfyxzz.com/CN/Y2023/V35/I7/557
[1] SUNG H,FERLAY J,SIEGEL R L,et al.Global Cancer Statistics 2020:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J].CA Cancer J Clin,2021,71(3):209-249.
[2] 中华人民共和国国家癌症中心.中国肿瘤登记工作指导手册(2016)[M].北京:人民卫生出版社,2016.
[3] 李辉章,杜灵彬.Joinpoint回归模型在肿瘤流行病学时间趋势分析中的应用[J].中华预防医学杂志,2020,54(8):908-912.
[4] ZHENG R S,ZHANG S W,ZENG H M,et al.Cancer incidence and mortality in China,2016[J].J Natl Cancer Cemt,2022,2(1):1-9.
[5] 丁萍飞,杜灵彬,李辉章,等.2010—2014年浙江省肿瘤登记地区胃癌发病与死亡分析[J].中国肿瘤,2019,28(2):93-99.
[6] 鲍萍萍,吴春晓,顾凯,等.上海市2016年胃癌发病特征及2002年至2016年胃癌发病趋势分析[J].诊断学理论与实践,2022,21(4):462-469.
[7] 鲍萍萍,龚杨明,彭鹏,等.2014年上海市恶性肿瘤发病和死亡特征分析[J].中国癌症杂志,2018,28(3):161-176.
[8] 钟文玲,黄少芬,林修全,等.福建省城乡居民消化系统恶性肿瘤死亡趋势分析[J].中国预防医学杂志,2017,18(4):272-276.
[9] 张旭,华婧,范康琼,等.2017年海南省肿瘤登记地区恶性肿瘤发病与死亡分析[J].中国癌症防治杂志,2023,15(1):45-51.
[10] PLUMMER M,FRANCESCHI S,DAVID J,et al.Global burden of gastric cancer attributable to Helicobacter pylori[J].Int J Cancer,2015,136:487-490.
[11] DONG J,THRIFT A P.Alcohol,smoking and risk of oesophago-gastric cancer[J].Best Pract Res Clin Gastroenterol,2017,31(5):509-517.
[12] 董妍,唐晓兰,孙卫东,等.宁波市某社区健康体检人群幽门螺杆菌感染状况调查与分析[J].中外医学研究,2014,12(26):80-81.
[13] 吕书红,李曼春,张学军,等.宁波市海曙区居民饮食与运动知识行为分析[J].中国健康教育,2004,20(10):884-887.
[14] 王永,应焱燕,陈洁平,等.2002—2022年宁波市恶性肿瘤死亡趋势分析[J].预防医学,2023,35(6):496-500,505.
[15] 贾善群,周乾宇,刘慧敏,等.2004—2018年中国消化道恶性肿瘤死亡趋势[J].中华疾病控制杂志,2021,25(9):1020-1025.
[16] GAO K,WU J.National trend of gastric cancer mortality in China(2003-2015):a population-based study[J].Cancer Commun,2019,39(1):1-5.
[17] 杨丹丹,姚学成,张昕涵,等.中国人群胃癌发病影响因素的Meta分析[J].预防医学,2022,34(6):561-570.
[18] 孟娜,俞浩,罗鹏飞,等.1990—2019年江苏省居民胃癌疾病负担变化趋势分析[J].中国慢性病预防与控制,2022,30(9):644-654.
[19] 徐倩倩,朱莹莹,冯宏伟,等.2018—2021年宁波市成人吸烟情况调查[J].预防医学,2022,34(5):461-465.
[20] GBD 2017 Stomach Cancer Collaborators.The global,regional,and national burden of stomach cancer in 195 countries,1990-2017:a systematic analysis for the Global Burden of Disease Study 2017BD 2017 Stomach Cancer Collaborators.The global,regional,and national burden of stomach cancer in 195 countries,1990-2017:a systematic analysis for the Global Burden of Disease Study 2017[J].Lancet Gastroenterol,2020,5(1):42-54.
[21] FREEDMAN N D,CHOW W H,GAO Y T,et al.Menstrual and reproductive factors and gastric cancer risk in a large prospective study of women[J].Gut,2007,56(12):1671-1677.
[22] WANG X M,HUANG X,FU Z,et al.Biphasic ER-α36-mediated estrogen signaling regulates growth of gastric cancer cells[J].Int J Oncol,2014,45(6):2325-2330.
[23] 中华人民共和国国家卫生健康委员会.关于印发原发性肺癌等18个肿瘤诊疗规范(2018年版)的通知[EB/OL]. [2023-05-24].http://www.nhc.gov.cn/yzygj/s7659/201812/b21802b199814ab7b1219b87de0cae51.shtml.
[1] 张铁威, 张艳, 刘冰, 秦康, 李标, 徐珏. 2013—2021年杭州市糖尿病死亡及疾病负担分析[J]. 预防医学, 2023, 35(9): 752-756.
[2] 郑伟, 张世勇, 杨纶砥, 熊华利. 基于年龄-时期-队列模型的1990—2019年我国艾滋病发病率趋势分析[J]. 预防医学, 2023, 35(8): 665-668,681.
[3] 李玉荣, 汪芬娟, 王冬飞, 林君英, 蒋园园, 高媛媛, 赵芳芳. 2015—2020年萧山区恶性肿瘤发病趋势分析[J]. 预防医学, 2023, 35(8): 687-691.
[4] 聂东梅, 李一鹏, 黄妍. 2012—2021年江门市4类慢性病早死概率分析[J]. 预防医学, 2023, 35(7): 602-606.
[5] 郑颖, 陈述, 钱棪梅, 唐晓翠, 李秀央. 2016—2022年金东区脑卒中发病趋势分析[J]. 预防医学, 2023, 35(7): 611-614.
[6] 安静, 李辉, 盛红斌, 蒋琦. 2012—2021年湖州市5岁以下儿童死亡监测资料分析[J]. 预防医学, 2023, 35(7): 628-631.
[7] 王永, 应焱燕, 陈洁平, 崔军, 包凯芳, 李思萱, 朱银潮, 王思嘉, 徐典, 冯宏伟. 2002—2022年宁波市恶性肿瘤死亡趋势分析[J]. 预防医学, 2023, 35(6): 496-500,505.
[8] 初里楠, 董奕, 李竹, 张燕, 朱丹红. 2014—2021年西城区恶性肿瘤死亡及减寿分析[J]. 预防医学, 2023, 35(5): 410-414.
[9] 崔俊鹏, 陆艳, 黄春妍, 华钰洁, 王临池. 2007—2021年苏州市女性乳腺癌死亡与减寿分析[J]. 预防医学, 2023, 35(5): 380-383.
[10] 周洁, 谭自明, 茹凉. 1990年与2019年中国0~14岁儿童肿瘤疾病负担分析[J]. 预防医学, 2023, 35(3): 205-209.
[11] 赵信星, 陈洪恩, 董晓, 邹泉, 梁晓峰, 吴静, 王长义. 2010—2021年南山区脑卒中发病趋势[J]. 预防医学, 2023, 35(3): 200-204.
[12] 张瑞洁, 纪威, 韩丽媛, 张良. 2012—2021年宁波市脑卒中发病和死亡趋势分析[J]. 预防医学, 2023, 35(3): 224-228.
[13] 许树红, 单杏仁, 卢巧玲, 孟海滨, 余佳琦. 2012—2021年绍兴市生殖道沙眼衣原体感染流行病学特征[J]. 预防医学, 2023, 35(2): 148-151.
[14] 项彩英, 汪德兵. 2011—2022年开化县肺癌发病和死亡趋势分析[J]. 预防医学, 2023, 35(10): 885-889.
[15] 刘锐, 蔺茂文, 江鸿, 李舒超, 张凡, 孙春. 2008—2022年荆州市丙型病毒性肝炎发病的年龄、时期、队列趋势分析[J]. 预防医学, 2023, 35(10): 871-876.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed